Complexo Hospitalario Universitario de Ferrol
Centro de atención
Hospital General de Granollers
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital General de Granollers (6)
2021
-
Impact of biological agents on postsurgical complications in inflammatory bowel disease: A multicentre study of geteccu
Journal of Clinical Medicine, Vol. 10, Núm. 19
2020
-
Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease
United European Gastroenterology Journal, Vol. 8, Núm. 9, pp. 1056-1066
2013
-
Indicadores de monitorización del proceso de soporte nutricional especializado
Farmacia Hospitalaria, Vol. 37, Núm. 1, pp. 15-26
2008
-
Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres
Diabetic Medicine, Vol. 25, Núm. 4, pp. 427-434
-
Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903
Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092
2002
-
Heterozygous familial hypercholesterolemia in Spain. Description of 819 non related cases
Medicina Clinica, Vol. 118, Núm. 13, pp. 487-492